A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

2017 Medicare Part D Formulary Search By Drug Letter

This is archive material for research purposes. Please see PDPFinder.com or MAFinder.com for current plans.
Select a Letter below:
Links to Summaries by State for LTC Drugs on LIS/SNP Plans:
AK  AL  AR  AZ  CA  CO  CT  DC  DE  FL  GA  HI  IA  ID  IL  IN  KS  KY  LA  MA  MD  ME  MI  MN  MO  MS  MT  NC  ND  NE  NH  NJ  NM  NV  NY  OH  OK  OR  PA  PR  RI  SC  SD  TN  TX  UT  VA  VT  WA  WI  WV  WY

Drug Names Containing the Letter W in Alphabetical Order.
Example: Lipitor® is found on letter page "L" as well as letter page "A" for Atorvastatin.

Drug Name
Packaging NDC On This Nbr of 2017 Formularies
PDPs MAPDs
COUMADIN 1 MG TABLET
(Warfarin Sodium)
100 EA   00056016970 44
PDPs
217
MAPDs
COUMADIN 10MG TABLET
(Warfarin Sodium)
100 BOT 00056017470 44
PDPs
217
MAPDs
COUMADIN 2MG TABLET
(Warfarin Sodium)
100 BOT 00056017070 44
PDPs
217
MAPDs
COUMADIN 2.5MG TABLET
(Warfarin Sodium)
1000 BOT 00056017690 44
PDPs
217
MAPDs
COUMADIN 3mg/1 1 BOTTLE per CARTON / 100 TABLET BOTTLE
(Warfarin Sodium)
1 BOTTLE in 1 CARTON / 10   00056018870 44
PDPs
217
MAPDs
COUMADIN 4mg/1 1 BOTTLE in 1 CARTON / 100 TABLET BOTTLE
(Warfarin Sodium)
1 BOTTLE in 1 CARTON / 10   00056016870 44
PDPs
217
MAPDs
COUMADIN 5MG TABLET
(Warfarin Sodium)
100 BOT 00056017270 44
PDPs
217
MAPDs
COUMADIN 6MG TABLET
(Warfarin Sodium)
100 BOT 00056018970 44
PDPs
217
MAPDs
COUMADIN 7.5MG TABLET
(Warfarin Sodium)
100 BOT 00056017370 44
PDPs
217
MAPDs
JANTOVEN 1MG TABLET
(Warfarin Sodium)
1000 BOT 00832121110 59
PDPs
333
MAPDs
JANTOVEN WARFARIN SODIUM 10MG TABLET (500 CT)
(Warfarin Sodium)
500 BOT 00832121950 59
PDPs
333
MAPDs
JANTOVEN WARFARIN SODIUM TABLET 2MG (1000 CT)
(Warfarin Sodium)
1000 BOT 00832121210 59
PDPs
333
MAPDs
JANTOVEN 2.5MG TABLET
(Warfarin Sodium)
100 BOT 00832121300 59
PDPs
333
MAPDs
JANTOVEN 3MG TABLET
(Warfarin Sodium)
1000 BOT 00832121410 59
PDPs
333
MAPDs
JANTOVEN 4MG TABLET
(Warfarin Sodium)
1000 BOT 00832121510 59
PDPs
333
MAPDs
JANTOVEN WARFARIN SODIUM 5MG TABLET (100 CT)
(Warfarin Sodium)
100 BOT 00832121600 59
PDPs
333
MAPDs
JANTOVEN 6MG TABLET
(Warfarin Sodium)
100 BOT 00832121700 59
PDPs
333
MAPDs
JANTOVEN 7.5MG TABLET
(Warfarin Sodium)
100 BOT 00832121800 59
PDPs
333
MAPDs
STERILE WATER FOR IRRIGATION
(Water For Irrigation, Sterile Irrigation)
1000ML BOTGL 00264210100 57
PDPs
311
MAPDs
WARFARIN SODIUM 1 MG TABLET (1000 CT)
(Warfarin Sodium)
1000 BOT 00555083105 59
PDPs
341
MAPDs
WARFARIN SODIUM 10 MG TABLET
(Warfarin Sodium)
100 EA   31722033501 59
PDPs
341
MAPDs
WARFARIN SODIUM 2 MG TABLET
(Warfarin Sodium)
    51672402803 59
PDPs
341
MAPDs
WARFARIN SODIUM 2.5 MG TABLET
(Warfarin Sodium)
100 EA   68382006401 59
PDPs
341
MAPDs
WARFARIN SODIUM 3 MG TABLET
(Warfarin Sodium)
1000 EA   31722033010 59
PDPs
341
MAPDs
WARFARIN SODIUM 4 MG TABLET
(Warfarin Sodium)
1000 EA   31722033110 59
PDPs
341
MAPDs
WARFARIN SODIUM 5 MG TABLET
(Warfarin Sodium)
    51672403203 59
PDPs
341
MAPDs
WARFARIN SODIUM 6MG TABLET
(Warfarin Sodium)
100 BOT 00555092602 59
PDPs
341
MAPDs
WARFARIN SODIUM 7.5 MG TABLET
(Warfarin Sodium)
100 EA   68382005801 59
PDPs
341
MAPDs
WELCHOL FOR ORAL SUSPENSION CITRUS FLAVOR 3.75 GM
(Colesevelam HCl)
30 PACKET BOX 65597090230 46
PDPs
284
MAPDs
WELCHOL 625MG TABLET
(Colesevelam HCl)
180 BOTPL 65597070118 45
PDPs
292
MAPDs
WELLBUTRIN SR 100MG TABLET SA
(Bupropion HCl)
60 BOT 00173094755 5
PDPs
10
MAPDs
WELLBUTRIN SR 150MG TABLET SA
(Bupropion HCl)
60 X 150 MG TABLETS BOT 00173013555 5
PDPs
10
MAPDs
WELLBUTRIN SR 200MG TABLET SA
(Bupropion HCl)
60 BOT 00173072200 5
PDPs
10
MAPDs
WELLBUTRIN XL 150 MG TABLET
(Bupropion HCl)
30 EA   00187073030 5
PDPs
10
MAPDs
WELLBUTRIN XL 300 MG TABLET
(Bupropion HCl)
30 EA   00187073130 5
PDPs
10
MAPDs
Wymzya fe chewable tablet
(Norethindrone and Ethinyl Estradiol, and Ferrous Fumarate)
    68180087311 32
PDPs
187
MAPDs



(Chart Source: Centers for Medicare and Medicaid files: CMS Data )





Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.